insights_auto
Why is GANX down 3.70%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
$1.04
arrow_downward
-3.70%(-0.040) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
Open
$1.12
High
$1.14
Low
$1.01
Mkt. cap
46.31M
Avg. vol.
529.90K
Volume
328.88K
52-wk high
$4.34
52-wk low
$0.96
EPS
-$0.43
Beta
0.29
Shares outstanding
44.52M
No. of employees
21
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
24/7 Wall St.
·
22 minutes ago
A $1,000 Investment in Ford a Decade Ago Is Worth Less Than $2,000, Under Half of What the S&P 500 Delivered
Longbridge
·
2 days ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
Traders Union
·
4 hours ago
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com